PanOmics
Comprehensive multi-omics data generation and analysis for advanced drug discovery.
Executive Summary
PanOmics is Evotec's comprehensive molecular analysis platform, encompassing genomics, transcriptomics, proteomics, and metabolomics. It provides deep and high-quality multi-omics data crucial for advanced drug discovery, enabling a holistic understanding of biological systems and disease mechanisms. The platform seamlessly integrates both data generation and analysis, often leveraging specialized tools like PanHunter software for processing complex biological omics data. PanOmics supports a wide range of research areas, including iPSC drug discovery, iPSC cell therapy, and toxicology prediction, driven by Evotec's extensive expertise in cell biology and state-of-the-art equipment. As a core component of Evotec's R&D efforts, PanOmics contributes significantly to target identification through frameworks like PanOmics TargetID and facilitates the development of novel therapeutic modalities, including iPSC cell lines with potential for functional cures.
Use Cases
- Advanced drug discovery and development
- Target identification and validation
- iPSC drug discovery and cell therapy research
- Toxicology prediction and assessment
- Generating multi-omics insights for biological research
Features
Visibility
- Multi-Omics Data Visualization: Visualize and explore complex genomics, transcriptomics, proteomics, and metabolomics data through interactive interfaces like PanHunter.
Intelligence
- Deep Biological Insights Generation: Generate comprehensive insights from integrated multi-omics data to understand biological systems and identify potential drug targets.
- Target Identification Framework: Utilize the PanOmics TargetID Framework for systematic identification of novel therapeutic targets.
Technical Specifications
- Architecture
- Integrated data generation and analysis platform, leveraging modular frameworks and API-driven data transfer for comprehensive multi-omics insights.
Pricing
- Model
- Service-based
- Starting Price
- Contact sales
- Target Customer
- Enterprise
- Free Trial
- No
About Evotec
Evotec is a life science company pioneering drug discovery and development by integrating breakthrough science with AI-driven innovation and advanced technologies. They accelerate the journey from concept to cure, offering drug discovery alliance and development services for the biopharma sector. Evotec partners with pharmaceutical and biotechnology companies, academic institutions, and other healthcare stakeholders globally.
Alternatives to PanOmics
- Pharma.AI by Insilico Medicine — Accelerating drug discovery and development with end-to-end generative AI and automation.
- phenAID by Ardigen — AI-powered image-based virtual screening and phenotypic profiling platform
- PipeBio Antibodies by Benchling — Accelerate AI-powered antibody discovery and development.
- POSH Platform by Insitro — AI-powered platform for gene function reconstruction and accelerated drug discovery.
- PreciousGPT by Insilico Medicine — AI models for digital -omics experiments and drug discovery.
- Recursion OS by Recursion Pharmaceuticals — Decoding biology to radically improve lives through AI-driven drug discovery.
- Relay Platform by Relay Therapeutics — Unlocking protein motion to transform drug discovery for previously intractable targets.
- TargetBench by Insilico Medicine — An AI-empowered benchmarking system for novel drug target identification models.